Stockreport

Bicara Therapeutics GAAP EPS of -$0.67 [Seeking Alpha]

Bicara Therapeutics Inc.  (BCAX) 
PDF Cash, Cash Equivalents and Investments: As of September 30, 2025, Bicara had cash, cash equivalents and investments of $407.6 million, compared to $489.7 million in cas [Read more]